Repeated subarachnoid administrations of autologous mesenchymal stromal cells supported in autologous plasma improve quality of life in patients suffering incomplete spinal cord injury.

Vaquero J, Zurita M, Rico MA, Bonilla C, Aguayo C, Fernández C, Tapiador N, Sevilla M, Morejón C, Montilla J, Martínez F, Marín E, Bustamante S, Vázquez D, Carballido J, Rodríguez A, Martínez P, García C, Ovejero M, Fernández MV, Neurological Cell Therapy Group

Open source

DOI: 10.1016/j.jcyt.2016.12.002
Published: 2017 Mar
Container: Cytotherapy
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jcyt.2016.12.002,
  title = {Repeated subarachnoid administrations of autologous mesenchymal stromal cells supported in autologous plasma improve quality of life in patients suffering incomplete spinal cord injury.},
  author = {Vaquero J and Zurita M and Rico MA and Bonilla C and Aguayo C and Fernández C and Tapiador N and Sevilla M and Morejón C and Montilla J and Martínez F and Marín E and Bustamante S and Vázquez D and Carballido J and Rodríguez A and Martínez P and García C and Ovejero M and Fernández MV and Neurological Cell Therapy Group},
  year = {2017},
  journal = {Cytotherapy},
  doi = {10.1016/j.jcyt.2016.12.002},
  url = {https://doi.org/10.1016/j.jcyt.2016.12.002}
}

RIS

TY  - JOUR
TI  - Repeated subarachnoid administrations of autologous mesenchymal stromal cells supported in autologous plasma improve quality of life in patients suffering incomplete spinal cord injury.
AU  - Vaquero J
AU  - Zurita M
AU  - Rico MA
AU  - Bonilla C
AU  - Aguayo C
AU  - Fernández C
AU  - Tapiador N
AU  - Sevilla M
AU  - Morejón C
AU  - Montilla J
AU  - Martínez F
AU  - Marín E
AU  - Bustamante S
AU  - Vázquez D
AU  - Carballido J
AU  - Rodríguez A
AU  - Martínez P
AU  - García C
AU  - Ovejero M
AU  - Fernández MV
AU  - Neurological Cell Therapy Group
PY  - 2017
JO  - Cytotherapy
DO  - 10.1016/j.jcyt.2016.12.002
UR  - https://doi.org/10.1016/j.jcyt.2016.12.002
ER  -

APA

J, V., M, Z., MA, R., C, B., C, A., C, F., N, T., M, S., C, M., J, M., F, M., E, M., S, B., D, V., J, C., A, R., P, M., C, G., M, O., MV, F., & Group, N. C. T. (2017). Repeated subarachnoid administrations of autologous mesenchymal stromal cells supported in autologous plasma improve quality of life in patients suffering incomplete spinal cord injury.. Cytotherapy. https://doi.org/10.1016/j.jcyt.2016.12.002

Source records

pubmed · retrieved 2026-09-26T17:54:58.568Z